January 11, 2026 (InterContinental San Francisco) — We’re pleased to announce that Stephen Squinto, Chief Investment Officer at J.P. Morgan Life Science Private Capital, will speak at the ACCESS ASIA BD Forum @ JPM 2026.
ACCESS ASIA, hosted by YAFO, builds on the success of ACCESS CHINA, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and strategic partners. Taking place on January 11, 2026, at the InterContinental San Francisco, the forum provides a global stage for Asian biotech companies to showcase their innovation, foster partnerships, and explore new business development opportunities. View more information at: https://biotochina.org/
About the speaker
Stephen Squinto, Ph.D., is Chief Investment Officer of J.P. Morgan Life Science Private Capital (“LSPC”) within J.P. Morgan Private Capital, a division of J.P. Morgan Global Alternatives in J.P. Morgan Asset Management.
Stephen joined J.P. Morgan Private Capital in 2022. Stephen leads the Life Science and Healthcare Private Capital investment platform at J.P. Morgan, which leverages the global scale, robust healthcare service ecosystem, and healthcare data intelligence of J.P. Morgan to invest in life sciences and healthcare companies.
Stephen has had a 35-year career in biotechnology and drug development. He was an early team member and an early company builder of Regeneron Pharmaceuticals, Co-Founder of Alexion Pharmaceuticals, and subsequently a highly successful investor at OrbiMed Advisors. While building Alexion, Dr. Squinto and his team were responsible for the discovery, development, approval, and commercial launch of several life-transforming biotechnology products worldwide, serving several rare disease patient communities. During his 8 years with OrbiMed, Dr. Squinto served on as many as 20 company boards, co-founded several OrbiMed-financed companies, and served as an operating executive of five. The investments led by Dr. Squinto at OrbiMed led to significant returns for the firm.
Stephen received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola
University of Chicago. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto previously held various joint academic positions at Tulane University and LSU Medical Schools.
About ACCESS ASIA BD Forum @ JPM 2026
ACCESS ASIA BD Forum @ JPM is scheduled to be held on January 11, 2026, at the InterContinental San Francisco, alongside the J.P. Morgan Healthcare Conference Week.
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.
Conference Name: ACCESS ASIA BD Forum @ JPM 2026
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/
MORE INFORMATION
Contact Us
Register as an attendee for ACCESS ASIA BD Forum @ JPM:
For more information, please contact:
Wendi Xiang | Wxiang@yafocapital.com
BioToChina.org 